BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 10408177)

  • 1. High incidence of meningioma among Hiroshima atomic bomb survivors.
    Shintani T; Hayakawa N; Hoshi M; Sumida M; Kurisu K; Oki S; Kodama Y; Kajikawa H; Inai K; Kamada N
    J Radiat Res; 1999 Mar; 40(1):49-57. PubMed ID: 10408177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial meningiomas among Nagasaki atomic bomb survivors.
    Shibata S; Sadamori N; Mine M; Sekine I
    Lancet; 1994 Dec 24-31; 344(8939-8940):1770. PubMed ID: 7997020
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of intracranial meningiomas in Nagasaki atomic-bomb survivors.
    Sadamori N; Shibata S; Mine M; Miyazaki H; Miyake H; Kurihara M; Tomonaga M; Sekine I; Okumura Y
    Int J Cancer; 1996 Jul; 67(3):318-22. PubMed ID: 8707402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid tumors in atomic bomb survivors in Hiroshima: a review.
    Takeichi N; Dohi K; Ito H; Yamamoto H; Mabuchi K; Yamamoto T; Shimaoka K; Yokoro K
    J Radiat Res; 1991 Mar; 32 Suppl():189-92. PubMed ID: 1762105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Did atomic bomb radiation influence the incidence of retinoblastoma in Nagasaki and Hiroshima?
    Amemiya T; Takano J; Choshi K
    Ophthalmic Paediatr Genet; 1993 Jun; 14(2):75-9. PubMed ID: 8233356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure.
    Preston DL; Ron E; Yonehara S; Kobuke T; Fujii H; Kishikawa M; Tokunaga M; Tokuoka S; Mabuchi K
    J Natl Cancer Inst; 2002 Oct; 94(20):1555-63. PubMed ID: 12381708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of meningioma in survivors of Hiroshima.
    Shintani T; Hayakawa N; Kamada N
    Lancet; 1997 May; 349(9062):1369. PubMed ID: 9149706
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutron-induced 63Ni in copper samples from Hiroshima and Nagasaki: a comprehensive presentation of results obtained at the Munich Maier-Leibnitz Laboratory.
    Rühm W; Carroll KL; Egbert SD; Faestermann T; Knie K; Korschinek G; Martinelli RE; Marchetti AA; McAninch JE; Rugel G; Straume T; Wallner A; Wallner C; Fujita S; Hasai H; Hoshi M; Shizuma K
    Radiat Environ Biophys; 2007 Nov; 46(4):327-38. PubMed ID: 17828415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and epidemiologic characteristics of first primary tumors of the central nervous system and related organs among atomic bomb survivors in Hiroshima and Nagasaki, 1958-1995.
    Yonehara S; Brenner AV; Kishikawa M; Inskip PD; Preston DL; Ron E; Mabuchi K; Tokuoka S
    Cancer; 2004 Oct; 101(7):1644-54. PubMed ID: 15378499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Excess Risk of Heart Disease Mortality among Hiroshima Atomic Bomb Male Survivors Exposed Near the Hypocenter.
    Hara N; Satoh K; Otani K; Kawakami H; Ohtaki M
    Hiroshima J Med Sci; 2016 Sep; 65(2):45-51. PubMed ID: 29989684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of multiple primary cancers in Nagasaki atomic bomb survivors: association with radiation exposure.
    Nakashima M; Kondo H; Miura S; Soda M; Hayashi T; Matsuo T; Yamashita S; Sekine I
    Cancer Sci; 2008 Jan; 99(1):87-92. PubMed ID: 17979995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary gland tumors in atomic bomb survivors, Hiroshima, Japan. I. Epidemiologic observations.
    Takeichi N; Hirose F; Yamamoto H
    Cancer; 1976 Dec; 38(6):2462-8. PubMed ID: 1000476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
    Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary gland tumors among atomic bomb survivors, 1950-1987.
    Saku T; Hayashi Y; Takahara O; Matsuura H; Tokunaga M; Tokunaga M; Tokuoka S; Soda M; Mabuchi K; Land CE
    Cancer; 1997 Apr; 79(8):1465-75. PubMed ID: 9118025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A long-term cohort study of the atomic-bomb survivors.
    Kodama K; Mabuchi K; Shigematsu I
    J Epidemiol; 1996 Aug; 6(3 Suppl):S95-105. PubMed ID: 8800280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid tumors in atomic bomb survivors in Hiroshima: epidemiological study from registered cases at Hiroshima Prefecture Tumor Tissue Registry, 1974-1987.
    Takeichi N; Dohi K; Yamamoto H; Ito H; Mabuchi K; Yamamoto T; Shimaoka K; Yokoro K
    Jpn J Cancer Res; 1991 Aug; 82(8):875-8. PubMed ID: 1910024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of circular asymmetry in cancer mortality of Hiroshima and Nagasaki A-bomb survivors.
    Peterson AV; Prentice RL; Ishimaru T; Kato H; Mason M
    Radiat Res; 1983 Jan; 93(1):184-99. PubMed ID: 6823505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of skin cancer among Nagasaki atomic bomb survivors.
    Sadamori N; Mine M; Honda T
    J Radiat Res; 1991 Dec; 32 Suppl 2():217-25. PubMed ID: 1823358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
    Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
    Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies.
    Mabuchi K; Soda M; Ron E; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Preston DL; Thompson DE
    Radiat Res; 1994 Feb; 137(2 Suppl):S1-16. PubMed ID: 8127951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.